INDUSTRY OVERVIEW
The Artificial Heart is Growing at 9.00% and is expected to reach 4Billion by 2030. Below mentioned are some of the dynamics shaping the Artificial Heart .Artificial Heart Market Size in (USD Billion) CAGR Growth Rate 9.00%
| Study Period | 2024-2030 |
| Market Size (2019): | 2Billion |
| Market Size (2030): | 4Billion |
| CAGR (2019 - 2030): | 9.00% |
| Fastest Growing Region | North America |
| Dominating Region | Europe |
www.www.htfmarketinsights.com
The Artificial Heart Market involves the development and distribution of mechanical hearts used in patients with severe heart failure. These devices serve as a temporary or long-term solution for patients awaiting heart transplants or those unable to undergo a transplant. The market is driven by the growing number of heart failure cases and advancements in medical technology. Innovations in the artificial heart market include more durable, energy-efficient designs, as well as biocompatible materials that reduce the risk of infection. Challenges include the high cost of devices, limited access to advanced healthcare facilities, and the need for ongoing patient monitoring. The Artificial Heart Market is expected to expand as the demand for heart failure treatments grows and new technologies improve the effectiveness and availability of artificial hearts.
Need More Details on Market Players and Competitors?
DOWNLOAD Sample Report
Market Drivers:
The key drivers in the market include technological advancements, increasing demand by consumers for innovative products, and government-friendly policies. Our research company combines industry reports with expert interviews and market analysis tools to identify and quantify drivers such as these. We review the current trends and gather data from leading industry publications and market research firms to decipher exactly how these and other factors are encouraging or dampening market growth.
- Increasing Prevalence Of Heart Failure
- Growing Aging Population
Market Restraints:
Some of the restraints to market growth may include regulatory challenges, high production costs, and disruptions in the supply chain. Our sources for these limitations include the regulation filings, industry surveys, and direct contributions from active participants within this marketplace. Tracking policy updates and economic reports further helps us to determine what kind of effect these factors have on the industry.
- High Cost Of Devices And Procedures
- Risk Of Complications
- Limited Availability Of Donor Hearts For Transplantation
Trends in the Market:
Among the trending ones are sustainability, digital transformation, and increasing importance of data analytics. Our research company is tracking these trends through the use of trend analysis tools, social media sentiment analysis, and industry benchmarking studies. Insights in emerging market preferences and technological advancements also come from surveys and focus groups.
- Minimally invasive implantation techniques
- Improved biocompatibility of materials
- Smaller and more durable devices
These include emerging markets, innovation in product development, and strategic partnerships. We identify these opportunities by performing market segmentation analysis, competitive landscape assessment, and investment trend evaluation. The data is collected based on industry reports, financial performance analysis for major players, and forecasting models for identifying future growth areas.
- Increasing Prevalence Of Heart Failure
- Growing Aging Population
Check Out Prices
Get Price
Regulation Shaping the Healthcare Industry
The healthcare industry is significantly influenced by a complex framework of regulations designed to ensure patient safety, efficacy of treatments, and the overall quality of care. Key regulatory areas include drug approval processes, medical device standards, and healthcare data protection. These regulations aim to maintain high standards for clinical practices and safeguard public health.Major Regulatory Bodies Worldwide
1. U.S. Food and Drug Administration (FDA): In the United States, the FDA is a pivotal regulatory authority overseeing the approval and monitoring of pharmaceuticals, medical devices, and biologics. The FDA sets stringent standards for product safety and efficacy, which significantly impacts market entry and ongoing compliance for healthcare companies.2. European Medicines Agency (EMA): The EMA plays a crucial role in the European Union, evaluating and supervising medicinal products. It provides centralized approval for drugs and ensures that products meet rigorous safety and efficacy standards across member states.
3. Health Canada: This agency regulates pharmaceuticals and medical devices in Canada, ensuring that products are safe, effective, and of high quality. Health Canada's regulations are aligned with international standards but tailored to meet national health needs.
4. World Health Organization (WHO): While not a regulatory body in the traditional sense, the WHO sets international health standards and provides guidelines that influence national regulatory frameworks. It plays a key role in global health policy and emergency response.
5. National Medical Products Administration (NMPA): In China, the NMPA regulates the approval and supervision of drugs and medical devices, with an increasing focus on aligning with global standards and facilitating market access.
Request for Customization
Get Customization
SWOT Analysis in the Healthcare Industry
SWOT analysis in the healthcare industry involves a structured assessment of Strengths, Weaknesses, Opportunities, and Threats to identify strategic advantages and areas for improvement.• Strengths: Evaluates internal factors such as advanced technology, skilled personnel, and strong brand reputation. For example, a hospital with cutting-edge medical equipment and specialized staff is considered to have a strong competitive edge.
• Weaknesses: Identifies internal limitations like outdated facilities, regulatory compliance issues, or high operational costs. Weaknesses could include inefficient processes or lack of innovation.
• Opportunities: Assesses external factors that could drive growth, such as emerging medical technologies, expanding markets, or favorable government policies. Opportunities might involve partnerships or new service lines.
• Threats: Examines external challenges such as increasing competition, changing regulations, or economic downturns. Threats might include new entrants with disruptive technologies or stricter regulatory requirements.
Market Segmentation
Segmentation by Type
- Total artificial hearts (TAHs)
- Left ventricular assist devices (LVADs)
- Right ventricular assist devices (RVADs)
- Biventricular assist devices (BiVADs)
Artificial Heart Market Segmentation by Type
www.htfmarketinsights.com
Segmentation by Application
- Treating heart failure
- Bridge to heart transplantation
- Destination therapy
- Cardiology
- Cardiac surgery
Artificial Heart Market Segmentation by Application
www.htfmarketinsights.com
Regional Outlook
The Europe currently holds a significant share of the market, primarily due to several key factors: increasing consumption rates, a burgeoning population, and robust economic momentum. These elements collectively drive demand, positioning this region as a leader in the market. On the other hand, North America is rapidly emerging as the fastest-growing area within the industry. This remarkable growth can be attributed to swift infrastructure development, the expansion of various industrial sectors, and a marked increase in consumer demand. These dynamics make this region a crucial player in shaping future market growth. In our report, we cover a comprehensive analysis of the regions and countries, includingRegions
- North America
- LATAM
- West Europe
- Central & Eastern Europe
- Northern Europe
- Southern Europe
- East Asia
- Southeast Asia
- South Asia
- Central Asia
- Oceania
- MEA
Fastest Growing Region
North America
Dominating Region
Europe
The company consistently allocates significant resources to expand its research capabilities, develop new medical technologies, and enhance its pharmaceutical portfolio. Johnson & Johnson's investments in R&D, coupled with strategic acquisitions and partnerships, reinforce its position as a major contributor to advancements in healthcare. This focus on innovation and market expansion underscores the critical importance of the North American region in the global healthcare landscape.
- SynCardia Systems
- Abiomed
- Medtronic
- Berlin Heart
- Carmat
- Getinge
- CircuLite
- Reddy Cardiac
- ReliantHeart
- Terumo
- CardioWest
- Organogenesis
- Boston Scientific
- Edwards Lifesciences
Artificial Heart Market Segmentation by Players
www.htfmarketinsights.com
Primary and Secondary Research
Primary research involves the collection of original data directly from sources in the healthcare industry. Approaches include the survey of health professionals, interviews with patients, focus groups, and clinical trials. This gives an overview of the current practice, the needs of the patient, and the interest in emerging trends. Firsthand information on the efficacy of new treatments, an assessment of market demand, and insight into changes in regulation can be sought only with primary research.Secondary Research: This is the investigation of existing information from a variety of sources, which may include industry reports, academic journals, government publications, and market research studies. Alfred secondary research empowers them to understand trends within industries, historical data, and competitive landscapes. It gives a wide view of the market dynamics and validates findings obtained from primary research. By combining both primary and secondary together, health organizations will be empowered to develop comprehensive strategies and make informed decisions based on a strong foundation built on data.
Report Infographics
|
Report Features |
Details |
|
Base Year |
2019 |
|
Based Year Market Size (2023) |
2Billion |
|
Historical Period |
2024 to 2019 |
|
CAGR (2019 to 2030) |
9.00% |
|
Forecast Period |
2019 to 2030 |
|
Forecasted Period Market Size (2030) |
4Billion |
|
Scope of the Report |
Total artificial hearts (TAHs), Left ventricular assist devices (LVADs), Right ventricular assist devices (RVADs), Biventricular assist devices (BiVADs), Treating heart failure, Bridge to heart transplantation, Destination therapy, Cardiology, Cardiac surgery. Sales Channel |
|
Regions Covered |
North America, LATAM, West Europe,Central & Eastern Europe, Northern Europe, Southern Europe, East Asia, Southeast Asia, South Asia, Central Asia, Oceania, MEA |
|
Companies Covered |
SynCardia Systems, Abiomed, Medtronic, Berlin Heart, Carmat, Getinge, CircuLite, Reddy Cardiac, ReliantHeart, Terumo, CardioWest, Organogenesis, Boston Scientific, Edwards Lifesciences |
|
Customization Scope |
15% Free Customization (For EG) |
|
Delivery Format |
PDF and Excel through Email |
Artificial Heart - Table of Contents
Chapter 1: Market Preface
- 1.1 Global Artificial Heart Market Landscape
- 1.2 Scope of the Study
- 1.3 Relevant Findings & Stakeholder Advantages
Chapter 2: Strategic Overview
- 2.1 Global Artificial Heart Market Outlook
- 2.2 Total Addressable Market versus Serviceable Market
- 2.3 Market Rivalry Projection
Chapter 3 : Global Artificial Heart Market Business Environment & Changing Dynamics
-
3.1 Growth Drivers
- 3.1.1 Increasing prevalence of heart failure
- 3.1.2 Growing aging population
-
3.2 Available Opportunities
- 3.2.1 Increasing prevalence of heart failure
-
3.3 Influencing Trends
- 3.3.1 Minimally invasive implantation techni
-
3.4 Challenges
- 3.4.1 High cost of devices and procedures
- 3.4.2 R
- 3.5 Regional Dynamics
Need only Qualitative Analysis? Get Prices
Sectional Purchase
Chapter 4 : Global Artificial Heart Industry Factors Assessment
- 4.1 Current Scenario
- 4.2 PEST Analysis
- 4.3 Business Environment - PORTER 5-Forces Analysis
- 4.3.1 Supplier Leverage
- 4.3.2 Bargaining Power of Buyers
- 4.3.3 Threat of Substitutes
- 4.3.4 Threat from New Entrant
- 4.3.5 Market Competition Level
- 4.4 Roadmap of Artificial Heart Market
- 4.5 Impact of Macro-Economic Factors
- 4.6 Market Entry Strategies
- 4.7 Political and Regulatory Landscape
- 4.8 Supply Chain Analysis
Chapter 5: Artificial Heart : Competition Benchmarking & Performance Evaluation
- 5.1 Global Artificial Heart Market Concentration Ratio
- 5.1.1 CR4, CR8 and HH Index
- 5.1.2 % Market Share - Top 3
- 5.1.3 Market Holding by Top 5
- 5.2 Market Position of Manufacturers by Artificial Heart Revenue 2019
- 5.3 Global Artificial Heart Sales Volume by Manufacturers (2019)
- 5.4 BCG Matrix
- 5.4 Market Entropy
- 5.5 Strategic Group Analysis
- 5.6 5C’s Analysis
Chapter 6: Global Artificial Heart Market: Company Profiles
- 6.1 SynCardia Systems
- 6.1.1 SynCardia Systems Company Overview
- 6.1.2 SynCardia Systems Product/Service Portfolio & Specifications
- 6.1.3 SynCardia Systems Key Financial Metrics
- 6.1.4 SynCardia Systems SWOT Analysis
- 6.1.5 SynCardia Systems Development Activities
- 6.2 Abiomed
- 6.3 Medtronic
- 6.4 Berlin Heart
- 6.5 Carmat
- 6.6 Getinge
- 6.7 CircuLite
- 6.8 Reddy Cardiac
- 6.9 ReliantHeart
- 6.10 Terumo
- 6.11 CardioWest
- 6.12 Organogenesis
- 6.13 Boston Scientific
- 6.14 Edwards Lifesciences
- 6.15 JenaValve
To View a Complete List of Players? Inquiry Now
Sectional Purchase
Chapter 7 : Global Artificial Heart by Type & Application (2024-2030)
-
7.1 Global Artificial Heart Market Revenue Analysis (USD Million) by Type (2024-2019)
- 7.1.1 Total Artificial Hearts (TAHs)
- 7.1.2 Left Ventricular Assist Devices (LVADs)
- 7.1.3 Right Ventricular Assist Devices (RVADs)
- 7.1.4 Biventricular Assist Devices (BiVADs)
- 7.1.5 Temporary Mechanical Circulatory Support Devices
-
7.2 Global Artificial Heart Market Revenue Analysis (USD Million) by Application (2024-2019)
- 7.2.1 Treating Heart Failure
- 7.2.2 Bridge To Heart Transplantation
- 7.2.3 Destination Therapy
- 7.2.4 Cardiology
- 7.2.5 Cardiac Surgery
- 7.3 Global Artificial Heart Market Revenue Analysis (USD Million) by Type (2019-2030)
- 7.4 Global Artificial Heart Market Revenue Analysis (USD Million) by Application (2019-2030)
Chapter 8 : North America Artificial Heart Market Breakdown by Country, Type & Application
- 8.1 North America Artificial Heart Market by Country (USD Million) & Sales Volume (Units) [2024-2019]
- 8.1.1 United States
- 8.1.2 Canada
-
8.2 North America Artificial Heart Market by Type (USD Million) & Sales Volume (Units) [2024-2019]
- 8.2.1 Total Artificial Hearts (TAHs)
- 8.2.2 Left Ventricular Assist Devices (LVADs)
- 8.2.3 Right Ventricular Assist Devices (RVADs)
- 8.2.4 Biventricular Assist Devices (BiVADs)
- 8.2.5 Temporary Mechanical Circulatory Support Devices
-
8.3 North America Artificial Heart Market by Application (USD Million) & Sales Volume (Units) [2024-2019]
- 8.3.1 Treating Heart Failure
- 8.3.2 Bridge To Heart Transplantation
- 8.3.3 Destination Therapy
- 8.3.4 Cardiology
- 8.3.5 Cardiac Surgery
- 8.4 North America Artificial Heart Market by Country (USD Million) & Sales Volume (Units) [2020-2030]
- 8.5 North America Artificial Heart Market by Type (USD Million) & Sales Volume (Units) [2020-2030]
- 8.6 North America Artificial Heart Market by Application (USD Million) & Sales Volume (Units) [2020-2030]
Looking for Section Purchase? Get Quote Now
Sectional Purchase
Chapter 9 : LATAM Artificial Heart Market Breakdown by Country, Type & Application
- 9.1 LATAM Artificial Heart Market by Country (USD Million) & Sales Volume (Units) [2024-2019]
- 9.1.1 Brazil
- 9.1.2 Argentina
- 9.1.3 Chile
- 9.1.4 Mexico
- 9.1.5 Rest of LATAM
-
9.2 LATAM Artificial Heart Market by Type (USD Million) & Sales Volume (Units) [2024-2019]
- 9.2.1 Total Artificial Hearts (TAHs)
- 9.2.2 Left Ventricular Assist Devices (LVADs)
- 9.2.3 Right Ventricular Assist Devices (RVADs)
- 9.2.4 Biventricular Assist Devices (BiVADs)
- 9.2.5 Temporary Mechanical Circulatory Support Devices
-
9.3 LATAM Artificial Heart Market by Application (USD Million) & Sales Volume (Units) [2024-2019]
- 9.3.1 Treating Heart Failure
- 9.3.2 Bridge To Heart Transplantation
- 9.3.3 Destination Therapy
- 9.3.4 Cardiology
- 9.3.5 Cardiac Surgery
- 9.4 LATAM Artificial Heart Market by Country (USD Million) & Sales Volume (Units) [2020-2030]
- 9.5 LATAM Artificial Heart Market by Type (USD Million) & Sales Volume (Units) [2020-2030]
- 9.6 LATAM Artificial Heart Market by Application (USD Million) & Sales Volume (Units) [2020-2030]
Chapter 10 : West Europe Artificial Heart Market Breakdown by Country, Type & Application
- 10.1 West Europe Artificial Heart Market by Country (USD Million) & Sales Volume (Units) [2024-2019]
- 10.1.1 Germany
- 10.1.2 France
- 10.1.3 Benelux
- 10.1.4 Switzerland
- 10.1.5 Rest of West Europe
-
10.2 West Europe Artificial Heart Market by Type (USD Million) & Sales Volume (Units) [2024-2019]
- 10.2.1 Total Artificial Hearts (TAHs)
- 10.2.2 Left Ventricular Assist Devices (LVADs)
- 10.2.3 Right Ventricular Assist Devices (RVADs)
- 10.2.4 Biventricular Assist Devices (BiVADs)
- 10.2.5 Temporary Mechanical Circulatory Support Devices
-
10.3 West Europe Artificial Heart Market by Application (USD Million) & Sales Volume (Units) [2024-2019]
- 10.3.1 Treating Heart Failure
- 10.3.2 Bridge To Heart Transplantation
- 10.3.3 Destination Therapy
- 10.3.4 Cardiology
- 10.3.5 Cardiac Surgery
- 10.4 West Europe Artificial Heart Market by Country (USD Million) & Sales Volume (Units) [2020-2030]
- 10.5 West Europe Artificial Heart Market by Type (USD Million) & Sales Volume (Units) [2020-2030]
- 10.6 West Europe Artificial Heart Market by Application (USD Million) & Sales Volume (Units) [2020-2030]
Chapter 11 : Central & Eastern Europe Artificial Heart Market Breakdown by Country, Type & Application
- 11.1 Central & Eastern Europe Artificial Heart Market by Country (USD Million) & Sales Volume (Units) [2024-2019]
- 11.1.1 Bulgaria
- 11.1.2 Poland
- 11.1.3 Hungary
- 11.1.4 Romania
- 11.1.5 Rest of CEE
-
11.2 Central & Eastern Europe Artificial Heart Market by Type (USD Million) & Sales Volume (Units) [2024-2019]
- 11.2.1 Total Artificial Hearts (TAHs)
- 11.2.2 Left Ventricular Assist Devices (LVADs)
- 11.2.3 Right Ventricular Assist Devices (RVADs)
- 11.2.4 Biventricular Assist Devices (BiVADs)
- 11.2.5 Temporary Mechanical Circulatory Support Devices
-
11.3 Central & Eastern Europe Artificial Heart Market by Application (USD Million) & Sales Volume (Units) [2024-2019]
- 11.3.1 Treating Heart Failure
- 11.3.2 Bridge To Heart Transplantation
- 11.3.3 Destination Therapy
- 11.3.4 Cardiology
- 11.3.5 Cardiac Surgery
- 11.4 Central & Eastern Europe Artificial Heart Market by Country (USD Million) & Sales Volume (Units) [2020-2030]
- 11.5 Central & Eastern Europe Artificial Heart Market by Type (USD Million) & Sales Volume (Units) [2020-2030]
- 11.6 Central & Eastern Europe Artificial Heart Market by Application (USD Million) & Sales Volume (Units) [2020-2030]
Chapter 12 : Northern Europe Artificial Heart Market Breakdown by Country, Type & Application
- 12.1 Northern Europe Artificial Heart Market by Country (USD Million) & Sales Volume (Units) [2024-2019]
- 12.1.1 The United Kingdom
- 12.1.2 Sweden
- 12.1.3 Norway
- 12.1.4 Baltics
- 12.1.5 Ireland
- 12.1.6 Rest of Northern Europe
-
12.2 Northern Europe Artificial Heart Market by Type (USD Million) & Sales Volume (Units) [2024-2019]
- 12.2.1 Total Artificial Hearts (TAHs)
- 12.2.2 Left Ventricular Assist Devices (LVADs)
- 12.2.3 Right Ventricular Assist Devices (RVADs)
- 12.2.4 Biventricular Assist Devices (BiVADs)
- 12.2.5 Temporary Mechanical Circulatory Support Devices
-
12.3 Northern Europe Artificial Heart Market by Application (USD Million) & Sales Volume (Units) [2024-2019]
- 12.3.1 Treating Heart Failure
- 12.3.2 Bridge To Heart Transplantation
- 12.3.3 Destination Therapy
- 12.3.4 Cardiology
- 12.3.5 Cardiac Surgery
- 12.4 Northern Europe Artificial Heart Market by Country (USD Million) & Sales Volume (Units) [2020-2030]
- 12.5 Northern Europe Artificial Heart Market by Type (USD Million) & Sales Volume (Units) [2020-2030]
- 12.6 Northern Europe Artificial Heart Market by Application (USD Million) & Sales Volume (Units) [2020-2030]
Chapter 13 : Southern Europe Artificial Heart Market Breakdown by Country, Type & Application
- 13.1 Southern Europe Artificial Heart Market by Country (USD Million) & Sales Volume (Units) [2024-2019]
- 13.1.1 Spain
- 13.1.2 Italy
- 13.1.3 Portugal
- 13.1.4 Greece
- 13.1.5 Rest of Southern Europe
-
13.2 Southern Europe Artificial Heart Market by Type (USD Million) & Sales Volume (Units) [2024-2019]
- 13.2.1 Total Artificial Hearts (TAHs)
- 13.2.2 Left Ventricular Assist Devices (LVADs)
- 13.2.3 Right Ventricular Assist Devices (RVADs)
- 13.2.4 Biventricular Assist Devices (BiVADs)
- 13.2.5 Temporary Mechanical Circulatory Support Devices
-
13.3 Southern Europe Artificial Heart Market by Application (USD Million) & Sales Volume (Units) [2024-2019]
- 13.3.1 Treating Heart Failure
- 13.3.2 Bridge To Heart Transplantation
- 13.3.3 Destination Therapy
- 13.3.4 Cardiology
- 13.3.5 Cardiac Surgery
- 13.4 Southern Europe Artificial Heart Market by Country (USD Million) & Sales Volume (Units) [2020-2030]
- 13.5 Southern Europe Artificial Heart Market by Type (USD Million) & Sales Volume (Units) [2020-2030]
- 13.6 Southern Europe Artificial Heart Market by Application (USD Million) & Sales Volume (Units) [2020-2030]
Chapter 14 : East Asia Artificial Heart Market Breakdown by Country, Type & Application
- 14.1 East Asia Artificial Heart Market by Country (USD Million) & Sales Volume (Units) [2024-2019]
- 14.1.1 China
- 14.1.2 Japan
- 14.1.3 South Korea
- 14.1.4 Taiwan
- 14.1.5 Others
-
14.2 East Asia Artificial Heart Market by Type (USD Million) & Sales Volume (Units) [2024-2019]
- 14.2.1 Total Artificial Hearts (TAHs)
- 14.2.2 Left Ventricular Assist Devices (LVADs)
- 14.2.3 Right Ventricular Assist Devices (RVADs)
- 14.2.4 Biventricular Assist Devices (BiVADs)
- 14.2.5 Temporary Mechanical Circulatory Support Devices
-
14.3 East Asia Artificial Heart Market by Application (USD Million) & Sales Volume (Units) [2024-2019]
- 14.3.1 Treating Heart Failure
- 14.3.2 Bridge To Heart Transplantation
- 14.3.3 Destination Therapy
- 14.3.4 Cardiology
- 14.3.5 Cardiac Surgery
- 14.4 East Asia Artificial Heart Market by Country (USD Million) & Sales Volume (Units) [2020-2030]
- 14.5 East Asia Artificial Heart Market by Type (USD Million) & Sales Volume (Units) [2020-2030]
- 14.6 East Asia Artificial Heart Market by Application (USD Million) & Sales Volume (Units) [2020-2030]
Chapter 15 : Southeast Asia Artificial Heart Market Breakdown by Country, Type & Application
- 15.1 Southeast Asia Artificial Heart Market by Country (USD Million) & Sales Volume (Units) [2024-2019]
- 15.1.1 Vietnam
- 15.1.2 Singapore
- 15.1.3 Thailand
- 15.1.4 Malaysia
- 15.1.5 Indonesia
- 15.1.6 Philippines
- 15.1.7 Rest of SEA Countries
-
15.2 Southeast Asia Artificial Heart Market by Type (USD Million) & Sales Volume (Units) [2024-2019]
- 15.2.1 Total Artificial Hearts (TAHs)
- 15.2.2 Left Ventricular Assist Devices (LVADs)
- 15.2.3 Right Ventricular Assist Devices (RVADs)
- 15.2.4 Biventricular Assist Devices (BiVADs)
- 15.2.5 Temporary Mechanical Circulatory Support Devices
-
15.3 Southeast Asia Artificial Heart Market by Application (USD Million) & Sales Volume (Units) [2024-2019]
- 15.3.1 Treating Heart Failure
- 15.3.2 Bridge To Heart Transplantation
- 15.3.3 Destination Therapy
- 15.3.4 Cardiology
- 15.3.5 Cardiac Surgery
- 15.4 Southeast Asia Artificial Heart Market by Country (USD Million) & Sales Volume (Units) [2020-2030]
- 15.5 Southeast Asia Artificial Heart Market by Type (USD Million) & Sales Volume (Units) [2020-2030]
- 15.6 Southeast Asia Artificial Heart Market by Application (USD Million) & Sales Volume (Units) [2020-2030]
Chapter 16 : South Asia Artificial Heart Market Breakdown by Country, Type & Application
- 16.1 South Asia Artificial Heart Market by Country (USD Million) & Sales Volume (Units) [2024-2019]
- 16.1.1 India
- 16.1.2 Bangladesh
- 16.1.3 Others
-
16.2 South Asia Artificial Heart Market by Type (USD Million) & Sales Volume (Units) [2024-2019]
- 16.2.1 Total Artificial Hearts (TAHs)
- 16.2.2 Left Ventricular Assist Devices (LVADs)
- 16.2.3 Right Ventricular Assist Devices (RVADs)
- 16.2.4 Biventricular Assist Devices (BiVADs)
- 16.2.5 Temporary Mechanical Circulatory Support Devices
-
16.3 South Asia Artificial Heart Market by Application (USD Million) & Sales Volume (Units) [2024-2019]
- 16.3.1 Treating Heart Failure
- 16.3.2 Bridge To Heart Transplantation
- 16.3.3 Destination Therapy
- 16.3.4 Cardiology
- 16.3.5 Cardiac Surgery
- 16.4 South Asia Artificial Heart Market by Country (USD Million) & Sales Volume (Units) [2020-2030]
- 16.5 South Asia Artificial Heart Market by Type (USD Million) & Sales Volume (Units) [2020-2030]
- 16.6 South Asia Artificial Heart Market by Application (USD Million) & Sales Volume (Units) [2020-2030]
Chapter 17 : Central Asia Artificial Heart Market Breakdown by Country, Type & Application
- 17.1 Central Asia Artificial Heart Market by Country (USD Million) & Sales Volume (Units) [2024-2019]
- 17.1.1 Kazakhstan
- 17.1.2 Tajikistan
- 17.1.3 Others
-
17.2 Central Asia Artificial Heart Market by Type (USD Million) & Sales Volume (Units) [2024-2019]
- 17.2.1 Total Artificial Hearts (TAHs)
- 17.2.2 Left Ventricular Assist Devices (LVADs)
- 17.2.3 Right Ventricular Assist Devices (RVADs)
- 17.2.4 Biventricular Assist Devices (BiVADs)
- 17.2.5 Temporary Mechanical Circulatory Support Devices
-
17.3 Central Asia Artificial Heart Market by Application (USD Million) & Sales Volume (Units) [2024-2019]
- 17.3.1 Treating Heart Failure
- 17.3.2 Bridge To Heart Transplantation
- 17.3.3 Destination Therapy
- 17.3.4 Cardiology
- 17.3.5 Cardiac Surgery
- 17.4 Central Asia Artificial Heart Market by Country (USD Million) & Sales Volume (Units) [2020-2030]
- 17.5 Central Asia Artificial Heart Market by Type (USD Million) & Sales Volume (Units) [2020-2030]
- 17.6 Central Asia Artificial Heart Market by Application (USD Million) & Sales Volume (Units) [2020-2030]
Chapter 18 : Oceania Artificial Heart Market Breakdown by Country, Type & Application
- 18.1 Oceania Artificial Heart Market by Country (USD Million) & Sales Volume (Units) [2024-2019]
- 18.1.1 Australia
- 18.1.2 New Zealand
- 18.1.3 Others
-
18.2 Oceania Artificial Heart Market by Type (USD Million) & Sales Volume (Units) [2024-2019]
- 18.2.1 Total Artificial Hearts (TAHs)
- 18.2.2 Left Ventricular Assist Devices (LVADs)
- 18.2.3 Right Ventricular Assist Devices (RVADs)
- 18.2.4 Biventricular Assist Devices (BiVADs)
- 18.2.5 Temporary Mechanical Circulatory Support Devices
-
18.3 Oceania Artificial Heart Market by Application (USD Million) & Sales Volume (Units) [2024-2019]
- 18.3.1 Treating Heart Failure
- 18.3.2 Bridge To Heart Transplantation
- 18.3.3 Destination Therapy
- 18.3.4 Cardiology
- 18.3.5 Cardiac Surgery
- 18.4 Oceania Artificial Heart Market by Country (USD Million) & Sales Volume (Units) [2020-2030]
- 18.5 Oceania Artificial Heart Market by Type (USD Million) & Sales Volume (Units) [2020-2030]
- 18.6 Oceania Artificial Heart Market by Application (USD Million) & Sales Volume (Units) [2020-2030]
Chapter 19 : MEA Artificial Heart Market Breakdown by Country, Type & Application
- 19.1 MEA Artificial Heart Market by Country (USD Million) & Sales Volume (Units) [2024-2019]
- 19.1.1 Turkey
- 19.1.2 South Africa
- 19.1.3 Egypt
- 19.1.4 UAE
- 19.1.5 Saudi Arabia
- 19.1.6 Israel
- 19.1.7 Rest of MEA
-
19.2 MEA Artificial Heart Market by Type (USD Million) & Sales Volume (Units) [2024-2019]
- 19.2.1 Total Artificial Hearts (TAHs)
- 19.2.2 Left Ventricular Assist Devices (LVADs)
- 19.2.3 Right Ventricular Assist Devices (RVADs)
- 19.2.4 Biventricular Assist Devices (BiVADs)
- 19.2.5 Temporary Mechanical Circulatory Support Devices
-
19.3 MEA Artificial Heart Market by Application (USD Million) & Sales Volume (Units) [2024-2019]
- 19.3.1 Treating Heart Failure
- 19.3.2 Bridge To Heart Transplantation
- 19.3.3 Destination Therapy
- 19.3.4 Cardiology
- 19.3.5 Cardiac Surgery
- 19.4 MEA Artificial Heart Market by Country (USD Million) & Sales Volume (Units) [2020-2030]
- 19.5 MEA Artificial Heart Market by Type (USD Million) & Sales Volume (Units) [2020-2030]
- 19.6 MEA Artificial Heart Market by Application (USD Million) & Sales Volume (Units) [2020-2030]
Chapter 20: Research Findings & Conclusion
- 20.1 Key Findings
- 20.2 Conclusion
Chapter 21: Methodology and Data Source
-
21.1 Research Methodology & Approach
- 21.1.1 Research Program/Design
- 21.1.2 Market Size Estimation
- 21.1.3 Market Breakdown and Data Triangulation
-
21.2 Data Source
- 21.2.1 Secondary Sources
- 21.2.2 Primary Sources
Chapter 22: Appendix & Disclaimer
- 22.1 Acronyms & bibliography
- 22.2 Disclaimer
Frequently Asked Questions (FAQ):
The Artificial Heart market is estimated to derive a market size of 4 Billion by 2030.
According to the report,the Artificial Heart Industry size is projected to reach 4 Billion, exhibiting a CAGR of 9.00% by 2030.
The changing dynamics and trends such as Minimally Invasive Implantation Techniques, Improved Biocompatibility Of Materials, Smaller And More Durable Devices, Wireless Power Transfer Technology are seen as major Game Changer in Global Artificial Heart Market.
- Increasing Prevalence Of Heart Failure
- Growing Aging Population
- Technological Advancements In Medical Devices
Some of the major challanges seen in Global Artificial Heart Market are High Cost Of Devices And Procedures, Risk Of Complications, Limited Availability Of Donor Hearts For Transplantation, Ethical Considerations.
The market opportunity is clear from the flow of investment into Global Artificial Heart Market, some of them are Increasing Prevalence Of Heart Failure, Growing Aging Population, Technological Advancements In Medical Devices.
SynCardia Systems, Abiomed, Medtronic, Berlin Heart, Carmat, Getinge, CircuLite, Reddy Cardiac, ReliantHeart, Terumo, CardioWest, Organogenesis, Boston Scientific, Edwards Lifesciences, JenaValve etc are the main players listed in the Global Artificial Heart Market Study.
Research paper of Global Artificial Heart Market shows that companies are making better progress than their supply chain peers –including suppliers, majorly in end-use applications such as Treating heart failure, Bridge to heart transplantation, Destination therapy, Cardiology, Cardiac surgery.
The Global Artificial Heart Market Study is segmented by Total artificial hearts (TAHs), Left ventricular assist devices (LVADs), Right ventricular assist devices (RVADs), Biventricular assist devices (BiVADs), Temporary mechanical circulatory support devices.
The Global Artificial Heart Market Study includes regional breakdown as North America, LATAM, West Europe,Central & Eastern Europe, Northern Europe, Southern Europe, East Asia, Southeast Asia, South Asia, Central Asia, Oceania, MEA
Historical Year: 2024 - Base year: 2019. Forecast period**: 2025 to 2030 [** unless otherwise stated]
The Artificial Heart Market involves the development and distribution of mechanical hearts used in patients with severe heart failure. These devices serve as a temporary or long-term solution for patients awaiting heart transplants or those unable to undergo a transplant. The market is driven by the growing number of heart failure cases and advancements in medical technology. Innovations in the artificial heart market include more durable, energy-efficient designs, as well as biocompatible materials that reduce the risk of infection. Challenges include the high cost of devices, limited access to advanced healthcare facilities, and the need for ongoing patient monitoring. The Artificial Heart Market is expected to expand as the demand for heart failure treatments grows and new technologies improve the effectiveness and availability of artificial hearts.
